Anastomosis Devices Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global anastomosis devices market size was estimated at USD 3.78 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.5% from 2023 to 2030. Rising surgical procedures and the growing prevalence of cardiovascular & gastrointestinal diseases are the key trends driving the market growth. The outbreak of COVID-19 considerably impacted the surgical practice. The pandemic created challenges for general surgery practice. It significantly impacted ways of working, open vs. minimally invasive surgical techniques, patient and staff safety, theatre workflow, and training & education.

In addition to the growing elderly population, there is a global increase in lifestyle-related conditions like cardiac diseases, diabetes, hypertension, obesity, and cancer. This rise is not limited to older individuals but also affects younger people. As the number of surgeries conducted worldwide continues to increase, there will be a corresponding surge in demand for anastomosis devices. These devices are crucial in facilitating quicker recovery, minimizing scarring, and reducing blood loss.

Surgical staplers and staples are increasingly utilized as alternatives to surgical sutures in medical procedures. These instruments offer several advantages, including reduced patient discomfort and faster healing of severe wounds or cuts. They are particularly common in minimally invasive surgeries. Additionally, surgical staplers and staples are employed in surgeries involving organ removal or reattachment, specifically in areas where the skin is close to the bone, to facilitate wound closure.

The increasing focus on enhancing patient outcomes is a key factor influencing the adoption of innovative anastomosis devices, thereby fueling market growth. For instance, in December 2020, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic introduced EEA Circular Stapler with Tri-Staple Technology. This is the first 3-row Circular Stapler with wide-ranging height staples indicated for use in colorectal procedures.

The introduction of technologically advanced products and favorable reimbursement scenarios in cardiac procedures, which comprises Coronary Bypass Graft Surgery (CABG), open-heart valve replacement, and angioplasty in developed countries are boosting the growth of the market for anastomosis devices. In January 2023, a start-up, Lydus Medical, received FDA clearance for their innovative device called Vesseal. It is a microvascular anastomosis aid device specifically designed for small arteries and serves as a suture deployment system, facilitating standardized omni-vessel anastomoses. With its user-friendly interface and efficient functionality, Vesseal enables medical professionals to perform simple, fast, safe, and effective procedures in microvascular anastomosis.

Product Type Insights

The disposable segment held the largest revenue share of 88.7% in 2022, owing to the availability of an array of disposable anastomotic products and greater market penetration. The majority of key players are involved in the production of disposable type of products. These products reduce the risk of cross-contamination, Surgical Site Infections (SSI), and other Healthcare-associated Infections (HAI). Another advantage of disposable anastomotic devices over reusable ones is that they reduce reprocessing costs and speed up the process.

The reusable anastomotic device is an emerging segment in the market for anastomosis devices. It is expected to witness a lucrative CAGR of 6.1% over the forecast period. The development of technologically advanced products and the rising need to reduce biomedical waste are some of the key factors anticipated to fuel the segment's growth in the forthcoming years.

Application Insights

The cardiovascular surgery segment dominated the anastomosis devices market with a revenue share of over 50.0% in 2022. According to the WHO, an estimated 17.9 million people died from cardiovascular diseases (CVD) in 2019, representing 32% of all deaths globally. The rising prevalence of CVD contributes to increased heart surgeries such as CABG.

The gastrointestinal surgery segment, comprising colorectal surgeries and large bowel resections, is anticipated to witness the highest CAGR of 5.7% over the forecast period. The growth is attributed to the increasing prevalence of colorectal cancer and other gastrointestinal diseases that require bowel resection. According to the American Cancer Society, in the U.S., 43,300 and 104,600 rectal and colon cancer were diagnosed in 2020

The prevalence of colorectal cancer is increasing in the Asia Pacific region, owing to which the market for anastomosis devices holds phenomenal potential. It also states that East Asian countries such as Japan, China, South Korea, and Singapore exhibited a two to four-fold increase in incidence over the last decade. Moreover, many products for use in gastrointestinal anastomosis are expected to be introduced in the market over the forecast period, thereby providing a lucrative growth platform to the market in the near future.

End-user Insights

The hospital segment dominated the market with a 57.6% revenue share in 2022 as hospitals offer superior patient care, thus witnessing lucrative growth. In January 2020, the American Heart Association stated that the number of in-patients owing to cardiovascular disease will likely increase by 23.6 million by 2030. Furthermore, several factors, such as the growing number of patients approaching hospitals owing to proper reimbursement facilities and accessibility to treatment at ease, are driving the segment growth.

The ambulatory care centers & clinics segment is projected to expand at the fastest CAGR of 5.6% over the forecast period. Increasing preference for outpatient care, as it is cost-effective and does not require a hospital stay, is likely to be the key factor driving the growth. Government initiatives and the availability of funding for ambulatory healthcare facilities are also anticipated to fuel the segment’s growth in the forthcoming years.

Regional Insights

North America accounted for the largest revenue share of 40.4% in 2022. The increasing prevalence of cardiovascular diseases and the growing number of R&D collaborations carried out by major regional players are projected to stimulate the growth of the regional market. Furthermore, growing access to medical assistance, increasing awareness regarding CVD and CHD, rising disposable income, and highly established R&D infrastructure are key factors contributing to the growth.

Asia Pacific (APAC) is anticipated to register the highest CAGR of 6.4% over the forecast period. Japan, China, and India are the key contributors to the growth. The regional market is estimated to experience the fastest growth during the forecast period due to improving economic conditions, growing healthcare awareness, and the increasing aging population in this region. Aged people are more susceptible to cardiovascular and gastrointestinal diseases, presenting a huge industry target population.

The rising interest of companies to expand their presence in the region, coupled with growing demand for anastomosis devices, is anticipated to drive the market. Additionally, increasing R&D activities and soaring healthcare expenditures are favoring the regional market growth.

Key Companies & Market Share Insights

The key players are undertaking various strategies such as mergers & acquisitions, new product developments, collaborations & partnerships, and expansion strategies to improve their market penetration. For instance, in March 2021, Vascular Graft Solutions Ltd. received marketing authorization from the FDA for the VIOLA. This is a new device for clampless proximal anastomosis in CABG. Some prominent players in the global anastomosis devices market include:

• Medtronic

• LivaNova PLC

• MAQUET Holding B.V. & Co. KG.

• Dextera Surgical Inc.

• Vitalitec Internaional Inc.

• Synovis Micro Companies Alliance, Inc.

• Ethicon US, LLC

• Peters Surgical

Anastomosis Devices Market Report Scope

Global Anastomosis Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global anastomosis devices market report based on product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Disposable

  • Reusable

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Cardiovascular Surgery

  • Gastrointestinal Surgery

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Ambulatory Care Centers & Clinics

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait